“New Depression Meds Not Effective Generally, But Drug Companies Insist Otherwise: Study”


The International Business Times covers a new study showing “trials for new antidepressant medications may not be applicable to the population at large.” “The finding, published in the Mayo Clinic Proceedings, shows recent trials are less generalizable than the prior studies, as researchers excluded most depressed patients from drug company-sponsored treatment studies.”

Article →

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time


  1. “Patients with co-morbid psychiatric disorders have become frequently excluded together with patients with any co-morbid Axis I disorder, which were twice as likely to be excluded in recent studies.”
    Like “co-morbid” means anything in psychiatry. But the fact that they cherry-pick people to increase their chances of getting a positive result is not surprising.

    Report comment